Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis

被引：14
|
作者：
Beyer, Natascha Helena [1 ,2 ]
Lueking, Angelika [3 ]
Kowald, Axel [3 ]
Frederiksen, Jette Lautrup [4 ]
Heegaard, Niels H. H. [1 ]
机构：
[1] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen S, Denmark
[2] Statens Serum Inst, Ctr Biosecur & Biopreparedness, DK-2300 Copenhagen S, Denmark
[3] Protagen AG, D-44227 Dortmund, Germany
[4] Glostrup Univ Hosp, Multiple Sclerosis Clin, Dept Neurol, DK-2600 Glostrup, Denmark
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2012年 / 242卷 / 1-2期
关键词：
Autoantibody profiling; Biomarker; Cerebrospinal fluid; Multiple sclerosis; ANTIMYELIN BASIC-PROTEIN; OLIGODENDROCYTE GLYCOPROTEIN ANTIBODIES; MONOSYMPTOMATIC OPTIC NEURITIS; MYELIN-ASSOCIATED GLYCOPROTEIN; ALPHA-B-CRYSTALLIN; NEUROFILAMENT LIGHT; PROTEOLIPID PROTEIN; ANTIPHOSPHOLIPID ANTIBODIES; ANTIGENIC CANDIDATES; SERUM AUTOANTIBODIES;
D O I：
10.1016/j.jneuroim.2011.08.013
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Using the UNIarray (R) marker technology platform, cerebrospinal fluid immunoglobulin G reactivities of 15 controls and 17 RRMS patients against human recombinant proteins were investigated. Patient cerebrospinal fluids were oligoclonal band positive and reactivities were compared to that of sex- and age-matched controls. We hereby aimed at the characterization of autoreactivity in patients with RRMS. Differences in auto-reactivities between control and RRMS samples were identified comprising autoantigens identified in this study only and previously reported autoantigens as well. A combination of the 10-15 most significant proteins may be investigated further as autoantigens for diagnostic purposes. Additional investigations may include minimizing the number of proteins used in such diagnostic tests. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码：26 / 32
页数：7
相关论文
共 50 条
  • [41] Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study
    Ruocco, Heloisa H.
    Brandao, Carlos Otavio
    Farias, Alessandro S.
    Oliveira, Celina
    Oliveira, Elaine C.
    Cendes, Fernando
    Damasceno, Benito P.
    Santos, Leonilda M. B.
    NEUROIMMUNOMODULATION, 2012, 19 (05) : 277 - 282
  • [42] Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome
    Sladkova, Vladimira
    Mares, Jan
    Lubenova, Blanka
    Zapletalova, Jana
    Stejskal, David
    Hlustik, Petr
    Kanovsky, Petr
    NEUROLOGICAL RESEARCH, 2011, 33 (04) : 415 - 420
  • [43] Facial emotion recognition in patients with relapsing-remitting multiple sclerosis
    Fereydouni, Soodabe
    Hadianfard, Habib
    Ashjazadeh, Nahid
    NEUROLOGY ASIA, 2019, 24 (04) : 327 - 332
  • [44] Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis
    Cocco, E.
    Marchi, P.
    Sardu, C.
    Russo, P.
    Paolillo, A.
    Mascia, M. G.
    Solla, M.
    Frau, J.
    Lorefice, L.
    Massole, S.
    Floris, G.
    Marrosu, M. G.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (08) : 975 - 980
  • [45] Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients
    Boldrini, Vinicius O.
    Marques, Ana M.
    Quintiliano, Raphael P. S.
    Moraes, Adriel S.
    Stella, Carla R. A. V.
    Longhini, Ana Leda F.
    Santos, Irene
    Andrade, Marilia
    Ferrari, Breno
    Damasceno, Alfredo
    Carneiro, Rafael P. D.
    Brandao, Carlos Otavio
    Farias, Alessandro S.
    Santos, Leonilda M. B.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [46] Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis
    Arnal-Garcia, Carmen
    Rosa Garcia-Montero, Ma
    Malaga, Ignacio
    Millan-Pascual, Jorge
    Oliva-Nacarino, Pedro
    Ramio-Torrenta, Lluis
    Oreja-Guevara, Celia
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2013, 17 (01) : 50 - 54
  • [47] Sexual dysfunction in female patients with relapsing-remitting multiple sclerosis
    Bartnik, Pawel
    Wielgos, Aleksandra
    Kacperczyk, Joanna
    Pisarz, Katarzyna
    Szymusik, Iwona
    Podlecka-Pietowska, Aleksandra
    Zakrzewska-Pniewska, Beata
    Wielgos, Miroslaw
    BRAIN AND BEHAVIOR, 2017, 7 (06):
  • [48] Development of laquinimod for relapsing-remitting multiple sclerosis
    Jeffery, Douglas R.
    FUTURE NEUROLOGY, 2008, 3 (06) : 641 - 648
  • [49] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
  • [50] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
12345